Research Article

Predicting Changes in Cardiovascular Risk Factors in Type 2 Diabetes in the Post-UKPDS Era: Longitudinal Analysis of the Swedish National Diabetes Register

Table 2

Estimates of GMM for risk factors from NDR data.

(1)(2)(3)(4)(5)
Risk factorsHbA1cbSystolic BPc (mmHg)TC : HDLLDL (mmolL−1)BMI (Kg/m2)
CoefficientLong-term effectCoefficientLong-term effectCoefficientLong-term effectCoefficientLong-term effectCoefficientLong-term effect

Constant3.055***5.546**1.647**1.938***6.832*
Ln (diabetes duration)0.182***0.384-0.050−0.0940.0990.216−0.059***−0.0910.106***0.561
Year 1a−0.144*−0.304NANANANA
Age at diagnosis−0.008***−0.0170.021*0.039−0.009**−0.020−0.007***−0.011−0.022**−0.116
Female−0.034*−0.072−0.064**−0.120−0.144***−0.3140.060***0.0930.1340.709
Smoking0.1920.4050.094***0.1760.0710.1550.0910.140−0.370***1.958
BMI0.015***0.0320.017***0.0320.021***0.0460.018**d
BMIsquaredNSNSNS−0.0003**d
Lag of HbA1c0.526***NANANA
Lag of SBPNAe0.466**NANA
Lag of TC : HDLNANA0.541***NA
Lag of LDLNANANA0.352***
Lag of BMINANANANA0.811***

(patients)44504158227420684284
Person years206992014410157953625447
Hansen test0.0530.5880.6540.4610.126
AR1f<0.001<0.001<0.001<0.001<0.001
AR20.3560.0950.2190.3100.078

***,**,*Denote significance level at the 1, 5, and 10%, respectively; Hansen test on overidentifying restrictions; AR1 and AR2 show the test on first and second order autocorrelation, respectively. aYear 1: 1 if diabetes duration = 1 year, 0 otherwise. bIn HbA1c equation, the smoking was an endogenous variable. cSystolic BP values transformed as systolic BP/10. dAs the BMI squared is significant, the long-term effect will be different for different levels of BMI. eThe covariate was not included in the estimation. fThe strong evidence against null hypothesis of no autocorrelation in the first-differenced errors is expected in the model.